Syschem India Rights Issue will open for subscription from 16 October 2023. the company aims for an issue size of ₹31.89 Crores through this rights Issue.
About the company
Syschem (India) Limited is engaged in the manufacturing of Bulk Drugs, Intermediates, Specialty Chemicals, and contract manufacturing. The company’s product portfolio includes Amoxycillin Trihydrate, Ampicillin Trihydrate, Cloxacillin Sodium, Dicloxacillin Sodium, Flucloxacillin Sodium, Oxacillin Sodium, Cefalexin Monohydrate, Cefadroxil Monohydrate, and Cefaclor. Syschem (India) is among the very few research-driven API manufacturing companies in India that provide customized solutions at a commercial scale. Its clientele comes from domestic as well as International markets. The company is headquartered in Chandigarh and has Manufacturing facilities located at Kalka, Panchkula (Haryana).
Objectives of the Issue
- To Expand the existing manufacturing facility for manufacturing of Amoxicillin and Cephalexin at unit located at Village Bargodam, Tehsil Kalka, Dist Panchkula, Haryana.
- Working capital requirements.
- General Corporate Purposes and Issue Expenses.
Syschem India Rights Issue Timetable
| Last Date to buy shares | 28 September 2023 |
| Record Date | 29 September 2023 |
| Credit of Rights Entitlements | |
| Bid/Offer Opens On | 16 October 2023 |
| Renunciation of Rights Entitlements | 23 October 2023 |
| Bid/Offer Closes On | 27 October 2023 |
| Deemed Date of Allotment | |
| Credit Date | |
| Listing Date |
Syschem India Rights Issue Details
| Issue Open | October 16, 2023 – October 27, 2023 |
| Security Name | Syschem (India) Limited |
| Issue Size (Shares) | 7,972,600 |
| Issue Size (Amount) | ₹31.89 Crores |
| Issue Price | ₹40 per share |
| Face Value | ₹10 per share |
| Listing At | BSE |
| Terms of Payment | The full amount of Rs. 40/- per equity shares is payable on application. |
| Entitlement | 1 Rights Equity Share(s) for every 4 fully paid-up Equity Shares held on Record Date |
Syschem India Financials
| Period Ended | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 77.17 | 59.81 | 92.71 |
| Revenue | 74.67 | 65.76 | 130.63 |
| Profit After Tax | -5.57 | -1.71 | 4.51 |
| Net Worth | 7.12 | 6.94 | 22.30 |
Syschem India Rights Issue Documents
Lead Manager(s)
Syschem India Registrar
Beetal Financial & Computer Services (P) Limited
Phone: +91 11 29961281
Email: beetalrta@gmail.com
Website: http://www.beetalfinancial.com
Syschem India Contact Information
Syschem (India) Limited
Village Bargodam,
Tehsil Kalka
Dist Panchkula – 133302
Phone: 0172-5070471
Email: info@syschem.in
Website: https://www.syschem.in/
Final Thoughts
Applying for the rights issue is purely a personal choice. make sure you make a detailed study about the company and rights issue before you make an investment decision.
Happy investing
